Robert Petit is Chief Scientific Officer at Advaxis, Inc. (ADXS). They have made 13 open-market trades across 1 company since 2013, most recently 2018-11-05.
CIK 0001576077
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $51K since 2013, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ADXS | 231,206 | $55K |
Shares reported on the most recent Form 4, priced at the 2018-11-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADXS | SELL | 2018-11-05 | 2018-11-07 | $0.58 | $2K | -18.6% | -34.7% | -36.4% |
| ADXS | SELL | 2018-11-02 | 2018-11-05 | $0.56 | $5K | -17.1% | -27.1% | -27.9% |
| ADXS | SELL | 2018-04-02 | 2018-04-03 | $1.62 | $4K | +7.5% | +7.5% | -5.6% |
| ADXS | SELL | 2017-11-06 | 2017-11-06 | $3.30 | $12K | +0.3% | -11.1% | -14.6% |
| ADXS | SELL | 2017-11-02 | 2017-11-02 | $3.19 | $40K | -6.6% | -7.2% | -7.5% |
| ADXS | SELL | 2017-03-31 | 2017-04-03 | $8.24 | $20K | -2.5% | +1.6% | -17.1% |
| ADXS | SELL | 2016-11-02 | 2016-11-02 | $8.32 | $23K | +19.7% | +0.5% | +9.3% |
| ADXS | SELL | 2016-05-02 | 2016-05-02 | $7.51 | $21K | -2.5% | +23.1% | +10.4% |
| ADXS | SELL | 2016-03-31 | 2016-04-01 | $9.13 | $30K | +2.0% | -17.5% | -14.5% |
| ADXS | SELL | 2016-01-29 | 2016-02-01 | $6.88 | $21K | -19.1% | +8.9% | +13.7% |
| ADXS | SELL | 2015-10-30 | 2015-11-03 | $12.26 | $35K | -17.7% | +0.5% | -25.2% |
| ADXS | SELL | 2015-07-31 | 2015-08-04 | $15.44 | $45K | -17.7% | +0.5% | +0.5% |
| ADXS | BUY | 2013-10-24 | 2013-10-28 | $4.00 | $51K | -17.7% | +0.5% | +0.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.